Duration Between Drainage and Ureteroscopic Lithotripsy
NCT ID: NCT06101563
Last Updated: 2024-11-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
96 participants
INTERVENTIONAL
2023-05-01
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Laser Lithotripsy for Ureteral Stones
NCT06465784
The Ideal Time Interval Between Repeated Shock Wave Lithotripsy Sessions For Renal Stones: A Randomized Controlled Trial
NCT04575480
Ureteric Stenting Versus Non-stenting Following Uncomplicated Ureteroscopic Lithotripsy
NCT04145063
Ideal Time of Stenting Prior to Ureteral Access Sheath for Stone Disease
NCT06761378
Uric Acid Based Renal Stones: Clinical, Metabolic and Genetic Characterization
NCT05634434
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early
Patients will be managed by ureteroscopic lithotripsy 7 days after drainage.
Early ureteroscopy
Patients will be managed by ureteroscopic lithotripsy 7 days after drainage.
Delayed
Patients will be managed by ureteroscopic lithotripsy 14-21 days after drainage.
Delayed Ureteroscopy
Patients will be managed by ureteroscopic lithotripsy 14-21 days after drainage.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early ureteroscopy
Patients will be managed by ureteroscopic lithotripsy 7 days after drainage.
Delayed Ureteroscopy
Patients will be managed by ureteroscopic lithotripsy 14-21 days after drainage.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Associated clinical evidence of acute upper urinary tract infection based on systemic inflammatory response syndrome (SIRS).
Exclusion Criteria
2. Bilateral obstructed kidneys necessitating bilateral drainage.
3. Associated emphysematous pyelonephritis or perinephric abscess.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed R EL-Nahas
Professor of Urology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yaser Osman, MD
Role: STUDY_CHAIR
Professor
Mahmoud Laymon, MD,MRCS
Role: STUDY_CHAIR
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Urology and Nephrology Center
Al Mansurah, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2371
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.